Barclays PLC Reduces Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Barclays PLC lessened its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 84.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 110,019 shares of the company's stock after selling 577,601 shares during the period. Barclays PLC owned approximately 0.12% of Acadia Healthcare worth $6,977,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of ACHC. Y Intercept Hong Kong Ltd lifted its position in Acadia Healthcare by 40.6% in the third quarter. Y Intercept Hong Kong Ltd now owns 36,605 shares of the company's stock valued at $2,321,000 after buying an additional 10,572 shares during the last quarter. Orion Portfolio Solutions LLC lifted its holdings in shares of Acadia Healthcare by 12.5% in the 3rd quarter. Orion Portfolio Solutions LLC now owns 18,166 shares of the company's stock worth $1,152,000 after acquiring an additional 2,013 shares during the last quarter. Wellington Management Group LLP boosted its position in shares of Acadia Healthcare by 12.2% during the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company's stock worth $739,250,000 after purchasing an additional 1,266,384 shares during the period. State Street Corp increased its holdings in Acadia Healthcare by 3.5% in the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company's stock valued at $178,811,000 after purchasing an additional 95,613 shares during the last quarter. Finally, Quantinno Capital Management LP raised its position in Acadia Healthcare by 153.0% in the third quarter. Quantinno Capital Management LP now owns 7,974 shares of the company's stock valued at $506,000 after purchasing an additional 4,822 shares during the period.

Acadia Healthcare Stock Down 1.2 %

Shares of ACHC stock traded down $0.46 on Thursday, reaching $38.59. 1,286,624 shares of the stock were exchanged, compared to its average volume of 1,048,428. The company has a market capitalization of $3.58 billion, a price-to-earnings ratio of 12.65, a PEG ratio of 1.77 and a beta of 1.29. The business's 50 day moving average price is $44.48 and its 200 day moving average price is $61.24. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a twelve month low of $36.50 and a twelve month high of $87.77.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. The business had revenue of $815.60 million during the quarter, compared to analysts' expectations of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business's quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.91 EPS. As a group, sell-side analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently weighed in on ACHC. Barclays dropped their price objective on Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating for the company in a research note on Friday, November 22nd. Royal Bank of Canada dropped their target price on Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating for the company in a research report on Monday, November 18th. KeyCorp began coverage on shares of Acadia Healthcare in a research report on Friday, October 11th. They set a "sector weight" rating on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a "hold" rating to a "buy" rating and lifted their price objective for the company from $45.00 to $75.00 in a report on Thursday, December 12th. Finally, Cantor Fitzgerald reissued a "neutral" rating and issued a $52.00 price target on shares of Acadia Healthcare in a research report on Tuesday, December 10th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, Acadia Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $75.44.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.